Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • February 05, 2021 9:51 AM | Becca Liebers (Administrator)

    Join us on National #WearRedDay to raise awareness about #HeartDisease, a leading cause of death in the US. Devoting a little time every day to care for yourself can go a long way toward protecting your heart health. 

    #APAOG #PAs #OBGYN #WomensHealth #OurHearts #HeartMonth 


  • February 04, 2021 10:40 AM | Becca Liebers (Administrator)

    ACOG | Clinical 

    All pregnant individuals who choose to receive the COVID-19 vaccine must be allowed to do so in alignment with their state and local vaccination allocation plan. This includes the estimated 330,000 health care workers who are pregnant and should be allowed to receive the vaccine as part of the first phase of vaccine distribution plans.  Reports of pregnant individuals being refused vaccination are concerning.

    Pregnant individuals who otherwise meet the criteria for COVID-19 vaccines should not be denied the opportunity to be vaccinated, should they choose to do so. Although a conversation with a clinician may be helpful for patients to aid in their decision-making, it should not be required prior to vaccination. 

    As the COVID-19 vaccine rollout continues, use must reflect the vaccines’ federal regulatory authorization as well as information and recommendations from the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, and expert healthcare organizations.

    Currently, available data demonstrate that pregnant individuals are at increased risk of more severe illness and death due to COVID-19 than their non-pregnant counterparts1. Providing pregnant individuals with the opportunity to be vaccinated can be critical to allowing them to protect themselves, particularly if their occupation puts them at increased risk of contracting the virus or if they have underlying and comorbid conditions. 

    Read more.

  • February 03, 2021 9:48 AM | Becca Liebers (Administrator)

    he 2021 AAPA Salary Survey is now open – please participate! Results provide the data you need to negotiate the compensation and benefits you deserve. If the pandemic has impacted your earnings or job status, we also want to hear from you so we can understand COVID-19’s effect on the profession. Complete the survey by February 28 -- members will receive a copy of the national summary report, and you’ll be entered to win one of 20 $50 gift cards.

    Click here to begin

  • February 01, 2021 2:23 PM | Becca Liebers (Administrator)

    February is International Prenatal Infection Prevention Month and we are sharing information with you to check out this month. Click here for more information on preventing infection before and during pregnancy. 



  • February 01, 2021 10:25 AM | Becca Liebers (Administrator)

    Practice Advisories

    New Committee Opinions

    New Practice Bulletins

    More from ACOG

  • February 01, 2021 8:10 AM | Becca Liebers (Administrator)

    ACOG

    The New York Times (1/31, Caron) reported researchers found that pregnant women transfer SARS-CoV-2 antibodies to their fetuses and transfer “more antibodies to their babies if they are infected earlier in their pregnancies.” The findings (1/29) were published in JAMA Pediatrics. Dr. Denise Jamieson, an obstetrician at Emory University and a member of ACOG’s Covid expert group, said the placenta is a complex organ that has been understudied and “What we really want to know is, do antibodies from the vaccine efficiently cross the placenta and protect the baby, the way we know happens in influenza and pertussis.” Dr. Mark Turrentine, a member of ACOG’s Covid expert group, said: “It’s plausible that the Covid vaccine will offer protection to both pregnant mothers and their infants. To me, this study highlights that inclusion of pregnant women in clinical trials such as the Covid-19 vaccine is essential, particularly when the benefit of vaccination is greater than the potential risk of a life-threatening disease.”

    CIDRAP (1/29, Van Beusekom) reported the researchers found in the study that “SARS-CoV-2 antibodies transferred across the placenta in 87% of pregnant women who had COVID-19 at some point, suggesting that newborns of seropositive mothers may have some protection against the novel coronavirus at birth.” 
  • January 27, 2021 9:48 AM | Becca Liebers (Administrator)

    Washington, DC – The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) are aware of the World Health Organization’s (WHO) recommendation to withhold COVID-19 vaccines from pregnant individuals unless they are at high risk of exposure. ACOG and SMFM continue to stress that both COVID-19 vaccines currently authorized by the U.S. Food and Drug Administration should not be withheld from pregnant individuals who choose to receive the vaccine. ACOG’s and SMFM’s current guidance on the COVID-19 vaccine in pregnant patients remains in place.

    Despite efforts by ACOG and SMFM to advocate for their inclusion, clinical trials that informed the emergency use authorization (EUA) of the vaccines did not include pregnant individuals. However, preliminary developmental and reproductive toxicity (DART) studies for both the Pfizer-BioNtech and Moderna vaccines are encouraging, with no safety signals reported. DART animal studies provide the first safety data to help inform the use of these vaccines in pregnancy until there are more data in this specific population. These studies do not indicate any adverse effects on female reproduction or fetal/embryonal development. ACOG and SMFM strongly urge manufacturers and federal agencies to collect and report data regarding the use of these vaccines in pregnancy.

    Read more. 

  • January 25, 2021 9:11 AM | Becca Liebers (Administrator)

    APAOG is now accepting partner applications for our women's health resource center. If you want to increase your exposure to PAs who practice in women's health, this opportunity is for you. Our premium and supporting partner options provide a range of benefits at great prices. Contact our office with any questions.

    Visit our Partners webpage for more information about this opportunity!

  • January 23, 2021 9:09 AM | Becca Liebers (Administrator)

    Today is #MaternalHealthAwarenessDay and APAOG is observing with our fellow women’s health professionals in order to improve maternal health outcomes and eliminate inequities for our patients and for moms across the country. #123ForMoms #PAs #OBGYN #WomensHealth #APAOG #ACOG 

  • January 04, 2021 9:56 AM | Becca Liebers (Administrator)

    Walk Through Steps of Administering LARC in CME
    Nisha McKenzie, PA-C, CSC, NCMP, IF and Deanna Bridge Najera, PA-C

    Nisha McKenzie, PA-C, CSC, NCMP, IF, founder of Women’s Health Collective in Grand Rapids, Michigan, and Deanna Bridge Najera, PA-C, clinician consultant in Carroll County, Maryland, team up to talk about Long-Acting Reversible Contraception (LARC). They are also the featured instructors in LARC CME available now on AAPA’s Learning Central. The CME covers how LARC use comes up and is discussed in real interactions with patients. It includes real-life scenarios often lacking in training but are quite helpful for clinical practice. Here, McKenzie and Najera share tips on LARC and treating patients.

    Read more.

Powered by Wild Apricot Membership Software